Delia Goletti - Infectious Diseases

Author Information

Delia Goletti is a researcher affiliated with the Department of Epidemiology and Preclinical Research, Translational Research Unit at the National Institute for Infectious Diseases "L. Spallanzani" in Rome, Italy. Her work primarily focuses on infectious diseases, with a significant emphasis on tuberculosis and the immune response to various infections, including COVID-19. Her research aims to advance understanding and improve clinical outcomes in infectious disease management.

Research Contributions

Delia Goletti has made substantial contributions to the field of infectious diseases. In 2022 alone, her research addressed various critical topics, including the role of platelets in tuberculosis, immune responses to SARS-CoV-2 vaccination in patients with autoimmune conditions, and the impact of armed conflict and displacement on tuberculosis burden in Europe. Additionally, she has explored strategies for latent tuberculosis screening in migrants and the effects of COVID-19 lockdown measures on tuberculosis control. Her work is characterized by a focus on both the clinical and epidemiological aspects of infectious diseases.

Aliases

Delia Goletti is also known by the aliases D Goletti and D. Goletti. These variations of her name are used in different publications and databases.

Publication and Citation Metrics

Metric	Value
Total Citation Count	17,179
h-index	71
Total Paper Count	380

Publications:

Platelets accumulate in lung lesions of tuberculosis patients and inhibit T-cell responses and Mycobacterium tuberculosis replication in macrophages.

DOI: 10.1002/eji.202149549

Year: 2022

Kinetics of the B- and T-Cell Immune Responses After 6 Months From SARS-CoV-2 mRNA Vaccination in Patients With Rheumatoid Arthritis

DOI: 10.3389/fimmu.2022.846753

Year: 2022

VIDAS® TB-IGRA reagents induce a CD4+ and CD8+ T-cell IFN-γ response for both TB infection and active TB.

DOI: 10.5588/ijtld.21.0478

Year: 2022

Immune-guided therapy of COVID-19.

DOI: 10.1158/2326-6066.CIR-21-0675

Year: 2022

Clinical standards for the diagnosis, treatment and prevention of TB infection

DOI: 10.5588/ijtld.21.0753

Year: 2022

Country-specific approaches to latent tuberculosis screening targeting migrants in EU/EEA* countries: A survey of national experts, September 2019 to February 2020

DOI: 10.2807/1560-7917.ES.2022.27.12.2002070

Year: 2022

Armed conflict and human displacement may lead to an increase in the burden of tuberculosis in Europe.

DOI: 10.1016/j.ijid.2022.03.040

Year: 2022

Humoral and cellular responses to spike of δ SARS-CoV-2 variant in vaccinated patients with Immune Mediated Inflammatory Diseases

DOI: 10.1016/j.ijid.2022.04.027

Year: 2022

Humoral- and T-Cell–Specific Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients With MS Using Different Disease-Modifying Therapies

DOI: 10.1212/WNL.0000000000013108

Year: 2022

Country-specific lockdown measures in response to the COVID-19 pandemic and its impact on tuberculosis control: a global study.

DOI: 10.36416/1806-3756/e20220087

Year: 2022

How are Sporozoites Detected?

What is the Impact on Public Health?

What are the Symptoms of HSV?

What is Protein Targeting?

What is Yellow Fever?

How is a Throat Swab Performed?

How Can Individuals Contribute to One Health?

What Ongoing Research is Being Conducted?

What is Pink Eye?

What is Immunodeficiency?

Partnered Content Networks

Relevant Topics